Xavier P.
- Country
- Spain
- Department
- Unitat de Risc Vascular
Research Overview
- J3L-MC-EZEB: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3819469 in Adults with Elevated Lipoprotein(a)
- Evaluation of Inclisiran's Efficacy in Reducing Major Adverse Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of ISIS 678354 Sodium Salt in Patients with Severe Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
Data & Insights
Has run more than one trial at 253 of 749 partner sites.
Specializations
Cardiovascular Disease Management
Specialized in investigating therapeutic approaches for atherosclerotic cardiovascular disease (ASCVD) and major adverse cardiovascular events (MACE). Focuses on innovative treatments to reduce cardiovascular mortality and improve patient outcomes.
- Coronary Heart Disease
- Myocardial Infarction Prevention
- Ischemic Stroke Management
Explores interventions for acute limb ischemia and arterial revascularization procedures.
Lipid Disorders
Conducts research in the treatment of severe hypertriglyceridemia (SHTG) and lipoprotein disorders. Investigates novel therapeutic agents for managing elevated triglyceride levels and abnormal lipid profiles.
- Triglyceride Level Management
- Lipoprotein(a) Reduction
- Familial Hypercholesterolemia
Evaluates long-term efficacy of lipid-lowering interventions in high-risk populations.
Preventive Cardiology
Specializes in cardiovascular risk reduction strategies for patients with established vascular disease. Studies innovative approaches to prevent cardiovascular complications in high-risk individuals.
- Cardiovascular Risk Assessment
- Primary Prevention Strategies
- Secondary Prevention Protocols
Evaluates long-term outcomes in cardiovascular disease prevention.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.